Loading…
Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions
Hot-spot mutations in the promoter region of telomerase reverse transcriptase (TERT promoter mutations) occur frequently in cutaneous and conjunctival melanoma and are exceedingly rare in uveal melanoma. No information is available on the presence of these mutations in the conjunctival melanocytic p...
Saved in:
Published in: | Investigative ophthalmology & visual science 2014-08, Vol.55 (9), p.6024-6030 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c293t-ff9472621a1c77b99d98d0799c22b16485526acab4e0bb8bc35cc802c263c34c3 |
---|---|
cites | |
container_end_page | 6030 |
container_issue | 9 |
container_start_page | 6024 |
container_title | Investigative ophthalmology & visual science |
container_volume | 55 |
creator | Koopmans, Anna E Ober, Kimberley Dubbink, Hendrikus J Paridaens, Dion Naus, Nicole C Belunek, Stephan Krist, Bart Post, Edward Zwarthoff, Ellen C de Klein, Annelies Verdijk, Robert M |
description | Hot-spot mutations in the promoter region of telomerase reverse transcriptase (TERT promoter mutations) occur frequently in cutaneous and conjunctival melanoma and are exceedingly rare in uveal melanoma. No information is available on the presence of these mutations in the conjunctival melanocytic precursor lesion primary acquired melanosis (PAM). We tested a cohort of uveal and conjunctival melanomas as well as conjunctival benign and premalignant melanocytic lesions for TERT promoter mutations in order to elucidate the role of these mutations in tumor progression.
TERT promoter mutation analysis on fresh tumor DNA and DNA from formalin-fixed, paraffin-embedded specimens was performed by SNaPshot analysis in 102 uveal melanomas, 39 conjunctival melanomas, 26 PAM with atypia, 14 PAM without atypia, and 56 conjunctival nevi.
Mutations of the TERT promoter were not identified in conjunctival nevi or PAM without atypia, but were detected in 2/25 (8%) of PAM with atypia and 16/39 (41%) of conjunctival melanomas. A single TERT promoter mutation was detected in 102 uveal melanomas (1%).
We present the second documented case of TERT promoter mutation in uveal melanoma. In comparison with other types of melanoma, TERT promoter mutations occur at extremely low frequency in uveal melanoma. TERT promoter mutations are frequent in conjunctival melanoma and occur at lower frequency in PAM with atypia but were not detected in benign conjunctival melanocytic lesions. These findings favor a pathogenetic tumor progression role for TERT promoter mutations in conjunctival melanocytic lesions. |
doi_str_mv | 10.1167/iovs.14-14901 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1566402913</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1566402913</sourcerecordid><originalsourceid>FETCH-LOGICAL-c293t-ff9472621a1c77b99d98d0799c22b16485526acab4e0bb8bc35cc802c263c34c3</originalsourceid><addsrcrecordid>eNptUU1PwzAMjRCIjcGRK8qRS0ecfuaIpvEhTQKhca5SN0WZmqQ07aT9E34uXTcQB0625edn-z1CroHNAZL0Trutn0MUQCQYnJApxDEP4jQLT__kE3Lh_YYxDsDZOZnwGGLBWTwlX6-t2spaWVRU2pJq09QaZaed9dRVdL18W9OmdcZ1qqWm78YW1Zb2WyXrcQad3fQWOz0QUaNqaZ2RBzZLC2X1hx2rplVG1kMlbfffEO46jbRWfr_8kpxVsvbq6hhn5P1huV48BauXx-fF_SpALsIuqCoRpTzhIAHTtBCiFFnJUiGQ8wKSKBskSCTKIlKsKLICwxgxYxx5EmIYYTgjtwfe4cnPXvkuN9qjqoeDlOt9DnGSRIwLCAdocIBi67xvVZU3rTay3eXA8r0Z-d6MHKJ8NGPA3xyp-8Ko8hf9o374DUZ9iWA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1566402913</pqid></control><display><type>article</type><title>Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions</title><source>PubMed (Medline)</source><creator>Koopmans, Anna E ; Ober, Kimberley ; Dubbink, Hendrikus J ; Paridaens, Dion ; Naus, Nicole C ; Belunek, Stephan ; Krist, Bart ; Post, Edward ; Zwarthoff, Ellen C ; de Klein, Annelies ; Verdijk, Robert M</creator><creatorcontrib>Koopmans, Anna E ; Ober, Kimberley ; Dubbink, Hendrikus J ; Paridaens, Dion ; Naus, Nicole C ; Belunek, Stephan ; Krist, Bart ; Post, Edward ; Zwarthoff, Ellen C ; de Klein, Annelies ; Verdijk, Robert M ; Rotterdam Ocular Melanoma Study Group</creatorcontrib><description>Hot-spot mutations in the promoter region of telomerase reverse transcriptase (TERT promoter mutations) occur frequently in cutaneous and conjunctival melanoma and are exceedingly rare in uveal melanoma. No information is available on the presence of these mutations in the conjunctival melanocytic precursor lesion primary acquired melanosis (PAM). We tested a cohort of uveal and conjunctival melanomas as well as conjunctival benign and premalignant melanocytic lesions for TERT promoter mutations in order to elucidate the role of these mutations in tumor progression.
TERT promoter mutation analysis on fresh tumor DNA and DNA from formalin-fixed, paraffin-embedded specimens was performed by SNaPshot analysis in 102 uveal melanomas, 39 conjunctival melanomas, 26 PAM with atypia, 14 PAM without atypia, and 56 conjunctival nevi.
Mutations of the TERT promoter were not identified in conjunctival nevi or PAM without atypia, but were detected in 2/25 (8%) of PAM with atypia and 16/39 (41%) of conjunctival melanomas. A single TERT promoter mutation was detected in 102 uveal melanomas (1%).
We present the second documented case of TERT promoter mutation in uveal melanoma. In comparison with other types of melanoma, TERT promoter mutations occur at extremely low frequency in uveal melanoma. TERT promoter mutations are frequent in conjunctival melanoma and occur at lower frequency in PAM with atypia but were not detected in benign conjunctival melanocytic lesions. These findings favor a pathogenetic tumor progression role for TERT promoter mutations in conjunctival melanocytic lesions.</description><identifier>ISSN: 1552-5783</identifier><identifier>EISSN: 1552-5783</identifier><identifier>DOI: 10.1167/iovs.14-14901</identifier><identifier>PMID: 25159205</identifier><language>eng</language><publisher>United States</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Conjunctival Neoplasms - epidemiology ; Conjunctival Neoplasms - genetics ; Conjunctival Neoplasms - pathology ; Disease Progression ; Female ; Humans ; Male ; Melanoma - epidemiology ; Melanoma - genetics ; Melanoma - pathology ; Melanosis - epidemiology ; Melanosis - genetics ; Melanosis - pathology ; Middle Aged ; Neoplasms - epidemiology ; Neoplasms - genetics ; Neoplasms - pathology ; Nevus, Pigmented - epidemiology ; Nevus, Pigmented - genetics ; Nevus, Pigmented - pathology ; Precancerous Conditions - epidemiology ; Precancerous Conditions - genetics ; Precancerous Conditions - pathology ; Prevalence ; Promoter Regions, Genetic - genetics ; Telomerase - genetics ; Uveal Neoplasms - epidemiology ; Uveal Neoplasms - genetics ; Uveal Neoplasms - pathology ; Young Adult</subject><ispartof>Investigative ophthalmology & visual science, 2014-08, Vol.55 (9), p.6024-6030</ispartof><rights>Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c293t-ff9472621a1c77b99d98d0799c22b16485526acab4e0bb8bc35cc802c263c34c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25159205$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Koopmans, Anna E</creatorcontrib><creatorcontrib>Ober, Kimberley</creatorcontrib><creatorcontrib>Dubbink, Hendrikus J</creatorcontrib><creatorcontrib>Paridaens, Dion</creatorcontrib><creatorcontrib>Naus, Nicole C</creatorcontrib><creatorcontrib>Belunek, Stephan</creatorcontrib><creatorcontrib>Krist, Bart</creatorcontrib><creatorcontrib>Post, Edward</creatorcontrib><creatorcontrib>Zwarthoff, Ellen C</creatorcontrib><creatorcontrib>de Klein, Annelies</creatorcontrib><creatorcontrib>Verdijk, Robert M</creatorcontrib><creatorcontrib>Rotterdam Ocular Melanoma Study Group</creatorcontrib><title>Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions</title><title>Investigative ophthalmology & visual science</title><addtitle>Invest Ophthalmol Vis Sci</addtitle><description>Hot-spot mutations in the promoter region of telomerase reverse transcriptase (TERT promoter mutations) occur frequently in cutaneous and conjunctival melanoma and are exceedingly rare in uveal melanoma. No information is available on the presence of these mutations in the conjunctival melanocytic precursor lesion primary acquired melanosis (PAM). We tested a cohort of uveal and conjunctival melanomas as well as conjunctival benign and premalignant melanocytic lesions for TERT promoter mutations in order to elucidate the role of these mutations in tumor progression.
TERT promoter mutation analysis on fresh tumor DNA and DNA from formalin-fixed, paraffin-embedded specimens was performed by SNaPshot analysis in 102 uveal melanomas, 39 conjunctival melanomas, 26 PAM with atypia, 14 PAM without atypia, and 56 conjunctival nevi.
Mutations of the TERT promoter were not identified in conjunctival nevi or PAM without atypia, but were detected in 2/25 (8%) of PAM with atypia and 16/39 (41%) of conjunctival melanomas. A single TERT promoter mutation was detected in 102 uveal melanomas (1%).
We present the second documented case of TERT promoter mutation in uveal melanoma. In comparison with other types of melanoma, TERT promoter mutations occur at extremely low frequency in uveal melanoma. TERT promoter mutations are frequent in conjunctival melanoma and occur at lower frequency in PAM with atypia but were not detected in benign conjunctival melanocytic lesions. These findings favor a pathogenetic tumor progression role for TERT promoter mutations in conjunctival melanocytic lesions.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Conjunctival Neoplasms - epidemiology</subject><subject>Conjunctival Neoplasms - genetics</subject><subject>Conjunctival Neoplasms - pathology</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Melanoma - epidemiology</subject><subject>Melanoma - genetics</subject><subject>Melanoma - pathology</subject><subject>Melanosis - epidemiology</subject><subject>Melanosis - genetics</subject><subject>Melanosis - pathology</subject><subject>Middle Aged</subject><subject>Neoplasms - epidemiology</subject><subject>Neoplasms - genetics</subject><subject>Neoplasms - pathology</subject><subject>Nevus, Pigmented - epidemiology</subject><subject>Nevus, Pigmented - genetics</subject><subject>Nevus, Pigmented - pathology</subject><subject>Precancerous Conditions - epidemiology</subject><subject>Precancerous Conditions - genetics</subject><subject>Precancerous Conditions - pathology</subject><subject>Prevalence</subject><subject>Promoter Regions, Genetic - genetics</subject><subject>Telomerase - genetics</subject><subject>Uveal Neoplasms - epidemiology</subject><subject>Uveal Neoplasms - genetics</subject><subject>Uveal Neoplasms - pathology</subject><subject>Young Adult</subject><issn>1552-5783</issn><issn>1552-5783</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNptUU1PwzAMjRCIjcGRK8qRS0ecfuaIpvEhTQKhca5SN0WZmqQ07aT9E34uXTcQB0625edn-z1CroHNAZL0Trutn0MUQCQYnJApxDEP4jQLT__kE3Lh_YYxDsDZOZnwGGLBWTwlX6-t2spaWVRU2pJq09QaZaed9dRVdL18W9OmdcZ1qqWm78YW1Zb2WyXrcQad3fQWOz0QUaNqaZ2RBzZLC2X1hx2rplVG1kMlbfffEO46jbRWfr_8kpxVsvbq6hhn5P1huV48BauXx-fF_SpALsIuqCoRpTzhIAHTtBCiFFnJUiGQ8wKSKBskSCTKIlKsKLICwxgxYxx5EmIYYTgjtwfe4cnPXvkuN9qjqoeDlOt9DnGSRIwLCAdocIBi67xvVZU3rTay3eXA8r0Z-d6MHKJ8NGPA3xyp-8Ko8hf9o374DUZ9iWA</recordid><startdate>20140826</startdate><enddate>20140826</enddate><creator>Koopmans, Anna E</creator><creator>Ober, Kimberley</creator><creator>Dubbink, Hendrikus J</creator><creator>Paridaens, Dion</creator><creator>Naus, Nicole C</creator><creator>Belunek, Stephan</creator><creator>Krist, Bart</creator><creator>Post, Edward</creator><creator>Zwarthoff, Ellen C</creator><creator>de Klein, Annelies</creator><creator>Verdijk, Robert M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20140826</creationdate><title>Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions</title><author>Koopmans, Anna E ; Ober, Kimberley ; Dubbink, Hendrikus J ; Paridaens, Dion ; Naus, Nicole C ; Belunek, Stephan ; Krist, Bart ; Post, Edward ; Zwarthoff, Ellen C ; de Klein, Annelies ; Verdijk, Robert M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c293t-ff9472621a1c77b99d98d0799c22b16485526acab4e0bb8bc35cc802c263c34c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Conjunctival Neoplasms - epidemiology</topic><topic>Conjunctival Neoplasms - genetics</topic><topic>Conjunctival Neoplasms - pathology</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Melanoma - epidemiology</topic><topic>Melanoma - genetics</topic><topic>Melanoma - pathology</topic><topic>Melanosis - epidemiology</topic><topic>Melanosis - genetics</topic><topic>Melanosis - pathology</topic><topic>Middle Aged</topic><topic>Neoplasms - epidemiology</topic><topic>Neoplasms - genetics</topic><topic>Neoplasms - pathology</topic><topic>Nevus, Pigmented - epidemiology</topic><topic>Nevus, Pigmented - genetics</topic><topic>Nevus, Pigmented - pathology</topic><topic>Precancerous Conditions - epidemiology</topic><topic>Precancerous Conditions - genetics</topic><topic>Precancerous Conditions - pathology</topic><topic>Prevalence</topic><topic>Promoter Regions, Genetic - genetics</topic><topic>Telomerase - genetics</topic><topic>Uveal Neoplasms - epidemiology</topic><topic>Uveal Neoplasms - genetics</topic><topic>Uveal Neoplasms - pathology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koopmans, Anna E</creatorcontrib><creatorcontrib>Ober, Kimberley</creatorcontrib><creatorcontrib>Dubbink, Hendrikus J</creatorcontrib><creatorcontrib>Paridaens, Dion</creatorcontrib><creatorcontrib>Naus, Nicole C</creatorcontrib><creatorcontrib>Belunek, Stephan</creatorcontrib><creatorcontrib>Krist, Bart</creatorcontrib><creatorcontrib>Post, Edward</creatorcontrib><creatorcontrib>Zwarthoff, Ellen C</creatorcontrib><creatorcontrib>de Klein, Annelies</creatorcontrib><creatorcontrib>Verdijk, Robert M</creatorcontrib><creatorcontrib>Rotterdam Ocular Melanoma Study Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Investigative ophthalmology & visual science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koopmans, Anna E</au><au>Ober, Kimberley</au><au>Dubbink, Hendrikus J</au><au>Paridaens, Dion</au><au>Naus, Nicole C</au><au>Belunek, Stephan</au><au>Krist, Bart</au><au>Post, Edward</au><au>Zwarthoff, Ellen C</au><au>de Klein, Annelies</au><au>Verdijk, Robert M</au><aucorp>Rotterdam Ocular Melanoma Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions</atitle><jtitle>Investigative ophthalmology & visual science</jtitle><addtitle>Invest Ophthalmol Vis Sci</addtitle><date>2014-08-26</date><risdate>2014</risdate><volume>55</volume><issue>9</issue><spage>6024</spage><epage>6030</epage><pages>6024-6030</pages><issn>1552-5783</issn><eissn>1552-5783</eissn><abstract>Hot-spot mutations in the promoter region of telomerase reverse transcriptase (TERT promoter mutations) occur frequently in cutaneous and conjunctival melanoma and are exceedingly rare in uveal melanoma. No information is available on the presence of these mutations in the conjunctival melanocytic precursor lesion primary acquired melanosis (PAM). We tested a cohort of uveal and conjunctival melanomas as well as conjunctival benign and premalignant melanocytic lesions for TERT promoter mutations in order to elucidate the role of these mutations in tumor progression.
TERT promoter mutation analysis on fresh tumor DNA and DNA from formalin-fixed, paraffin-embedded specimens was performed by SNaPshot analysis in 102 uveal melanomas, 39 conjunctival melanomas, 26 PAM with atypia, 14 PAM without atypia, and 56 conjunctival nevi.
Mutations of the TERT promoter were not identified in conjunctival nevi or PAM without atypia, but were detected in 2/25 (8%) of PAM with atypia and 16/39 (41%) of conjunctival melanomas. A single TERT promoter mutation was detected in 102 uveal melanomas (1%).
We present the second documented case of TERT promoter mutation in uveal melanoma. In comparison with other types of melanoma, TERT promoter mutations occur at extremely low frequency in uveal melanoma. TERT promoter mutations are frequent in conjunctival melanoma and occur at lower frequency in PAM with atypia but were not detected in benign conjunctival melanocytic lesions. These findings favor a pathogenetic tumor progression role for TERT promoter mutations in conjunctival melanocytic lesions.</abstract><cop>United States</cop><pmid>25159205</pmid><doi>10.1167/iovs.14-14901</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1552-5783 |
ispartof | Investigative ophthalmology & visual science, 2014-08, Vol.55 (9), p.6024-6030 |
issn | 1552-5783 1552-5783 |
language | eng |
recordid | cdi_proquest_miscellaneous_1566402913 |
source | PubMed (Medline) |
subjects | Adult Aged Aged, 80 and over Conjunctival Neoplasms - epidemiology Conjunctival Neoplasms - genetics Conjunctival Neoplasms - pathology Disease Progression Female Humans Male Melanoma - epidemiology Melanoma - genetics Melanoma - pathology Melanosis - epidemiology Melanosis - genetics Melanosis - pathology Middle Aged Neoplasms - epidemiology Neoplasms - genetics Neoplasms - pathology Nevus, Pigmented - epidemiology Nevus, Pigmented - genetics Nevus, Pigmented - pathology Precancerous Conditions - epidemiology Precancerous Conditions - genetics Precancerous Conditions - pathology Prevalence Promoter Regions, Genetic - genetics Telomerase - genetics Uveal Neoplasms - epidemiology Uveal Neoplasms - genetics Uveal Neoplasms - pathology Young Adult |
title | Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T02%3A47%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20and%20implications%20of%20TERT%20promoter%20mutation%20in%20uveal%20and%20conjunctival%20melanoma%20and%20in%20benign%20and%20premalignant%20conjunctival%20melanocytic%20lesions&rft.jtitle=Investigative%20ophthalmology%20&%20visual%20science&rft.au=Koopmans,%20Anna%20E&rft.aucorp=Rotterdam%20Ocular%20Melanoma%20Study%20Group&rft.date=2014-08-26&rft.volume=55&rft.issue=9&rft.spage=6024&rft.epage=6030&rft.pages=6024-6030&rft.issn=1552-5783&rft.eissn=1552-5783&rft_id=info:doi/10.1167/iovs.14-14901&rft_dat=%3Cproquest_cross%3E1566402913%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c293t-ff9472621a1c77b99d98d0799c22b16485526acab4e0bb8bc35cc802c263c34c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1566402913&rft_id=info:pmid/25159205&rfr_iscdi=true |